Latest Breaking News On - ப்ரெஸெஂட் ஆதாரம் - Page 1 : comparemela.com

On April 7, 2021, the Federal Circuit decided Apple Inc. v. Qualcomm Inc., where it held that Apple lacked standing to appeal the final written decisions in two inter partes review (“IPR”) proceedings before the U.S. Patent Trial and Appeal Board (“PTAB”). Shortly before that, on March 22, 2021, almost one year after the Federal Circuit issued an earlier standing opinion in Argentum Pharm. LLC v. Novartis Pharm. Corp., 956 F.3d 1374 (Fed. Cir. 2020), the Supreme Court denied a petition for a writ of certiorari by Argentum. The Federal Circuit’s recent decision in Apple and the Supreme Court’s recent denial of certiorari in

United statesNovartis pharmNovarti gilenyaMedicis pharmChugai pharmAmerigen pharmPharma gmUnited technologies corpParagon bioteck incPfizer incAltaire pharm incImmunogen incSpokeo incApotex incUnited technologiesPhigenix inc